Detalhe da pesquisa
1.
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.
Nature
; 610(7930): 161-172, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171284
2.
A human receptor occupancy assay to measure anti-PD-1 binding in patients with prior anti-PD-1.
Cytometry A
; 99(8): 832-843, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704890
3.
The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies.
Pharm Res
; 36(3): 47, 2019 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721414
4.
TriFabs--Trivalent IgG-Shaped Bispecific Antibody Derivatives: Design, Generation, Characterization and Application for Targeted Payload Delivery.
Int J Mol Sci
; 16(11): 27497-507, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26593903
5.
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319064
6.
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
J Clin Invest
; 117(12): 3868-78, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18060034
7.
Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2.
MAbs
; 8(3): 562-73, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864324
8.
Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Arthritis Rheumatol
; 67(1): 51-62, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25303306
9.
A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood.
PLoS One
; 9(2): e86184, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24503933
10.
Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies.
MAbs
; 5(4): 576-86, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23765230
11.
A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.
PLoS One
; 8(2): e54923, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23405099